Indeed, although the treatment options of BC with surgery, chemotherapy, aromatase inhibitors, hormone receptor modulators, and anti-Human Epidermal Growth Factor Receptor 2 (HER2)-Therapy [3,4,5] have developed tremendously in recent years, consistently high mortality rates due to tumor metastasis remain [6,7]. This evidence concerns the gene ERBB2 and breast cancer.